Syndax Pharmaceuticals, Inc. (SNDX)
23.68
-0.09
(-0.38%)
USD |
NASDAQ |
Mar 18, 15:59
23.67
-0.01
(-0.04%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Liabilities (Quarterly) : 465.08M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Cogent Biosciences, Inc. | 301.24M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 529.71M |
| Shareholders Equity (Quarterly) | 64.63M |
| Debt to Equity Ratio | 5.345 |
| Current Ratio | 4.396 |
| Net Debt Paydown Yield | -3.75% |